bromhexine

Also known as N-Cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)amine, Tauglicolo, Fluibron, Bromexina, Bromhexina, Bromhexinum, 3,5-Dibromo-N(alpha)-cyclohexyl-N(alpha)-methyltoluene-alpha-2-diamine

Bromhexine, sold under the brand name Bisolvon among others, is a mucolytic drug used in the treatment of respiratory disorders associated with viscid or excessive mucus. It was developed in the research laboratory of Boehringer Ingelheim in the late 1950s as an active ingredient for pharmaceutical use, patented in 1961, introduced in 1963 under the trademark of Bisolvon® and came into medical use in 1966.